Neurological Institute Outcomes
Headache
Episodic Migraine
Outcomes of Treatment in Episodic Migraine Patients (N = 2826)
2021
HIT-6 = Headache Impact Test, PHQ-9 = Patient Health Questionnaire, PROMIS = Patient Reported Outcome Measurement Information System
In 2021, 2826 patients with episodic migraine completed at least 1 questionnaire following treatment. The median interval between initial appointment and follow-up was 265 days (range, 7-713). Of the 1927 patients who reported HIT-6 scores > 50 at initial evaluation, 69% reported stable or improved scores at their second visit.¹ Of the 1104 patients who reported initial PROMIS Global Health ˃ one-half SD below the normative mean,² 38% reported improvement. Of the 822 patients who completed the PHQ-9 at 2 visits and reported initial depressive symptoms above the cutoff of ≥ 10 points,³ 36% reported improvement of depressive symptoms on follow-up.